Ducentis Biotherapeutics Ltd.

Active09307415 Private limited company
Incorporated
12 November 2014 (11 years)
Previously known as
Tripos Biopharma Ltd. (until 6 July 2015)
Ducentis Biotherapeutics Ltd. (until 8 May 2015)
Deucentis Limited (until 17 November 2014)
This list may be incomplete. See all names on Companies House
Industry
Research and experimental development on biotechnology (72110)
Directors
Latha Vairavan
Masaru Matsuda
Patrick Burnett
Owned by
Arcutis Biotherapeutics, Inc.
Accounts type
Small
Region
South West
Address
Suite 2
Ground Floor
Templeback
10 Temple Back
Bristol
BS1 6FL

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
10 March 2027
Last conf. stmt
24 February 2026

Charges

Total
2
Outstanding
2
Part satisfied
0
Satisfied
0

Officers 3 active

Officer details are public data from the Companies House register.

Vairavan, Latha
Director · Appointed 13 June 2025
American
Born August 1977 (49)
Matsuda, Masaru
Director · Appointed 6 December 2023
American
Born March 1970 (56)
Burnett, Patrick
Director · Appointed 9 September 2022
American
Born May 1971 (55)
Officer history (14 former)
13 June 2025
Appointed Vairavan, Latha as Director
6 May 2025
Resigned Topper, David Joseph as Director
30 September 2024
Appointed Topper, David Joseph as Director
21 August 2024
Resigned Robison, Jessica Lynn as Director
15 May 2024
Resigned Moore, Matthew as Director
6 December 2023
Appointed Matsuda, Masaru as Director
6 December 2023
Appointed Robison, Jessica Lynn as Director
31 August 2023
Resigned Burrows, Scott Loren as Director
9 September 2022
Resigned Terlouw, Clare Elizabeth as Director
9 September 2022
9 September 2022
Appointed Burrows, Scott Loren as Director
9 September 2022
Resigned Huxley, Philip, Dr as Director
9 September 2022
Resigned Watt, Alan Paul, Dr as Director
9 September 2022
Resigned Huxley, Philip, Dr as Secretary
9 September 2022
Appointed Burnett, Patrick as Director
9 September 2022
Appointed Moore, Matthew as Director
9 September 2022
Resigned Ashfield, Rebecca, Dr as Director
9 September 2022
Resigned Mica, Andrea Giacomo as Director
9 September 2022
Resigned Lenoble, Philippe as Director
6 August 2021
Appointed Watt, Alan Paul, Dr as Director
10 June 2021
Appointed Terlouw, Clare Elizabeth as Director
28 April 2021
12 June 2019
Appointed Mica, Andrea Giacomo as Director
12 June 2019
Appointed Lenoble, Philippe as Director
12 June 2019
Appointed Holbrook, David Mark Anthony, Dr as Director
9 July 2015
Appointed Ashfield, Rebecca, Dr as Director
9 July 2015
Appointed Blackbourn, David John, Professor as Director
2 May 2015
Appointed Huxley, Philip, Dr as Secretary
1 May 2015
Resigned Morris, Toby as Secretary
12 November 2014
Appointed Morris, Toby as Secretary
12 November 2014
Appointed Huxley, Philip, Dr as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Arcutis Biotherapeutics, Inc.
Corporate entity · Notified 9 September 2022
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Delaware Corporation
Former controllers (3)
9 September 2022
Ceased Lifearc — Owns 25–50% of shares
9 September 2022
Ceased Philip Huxley — Has significant influence or control
28 April 2021
Ceased David Mark Anthony Holbrook — Owns 25–50% of shares (as a firm)

Financials

Balance sheet as at 31 December 2025 · small accounts

Profit
(£5,937,214)

Trend

Shareholder Funds
(£10.0M) (£5.0M) £0 £5.0M 2019 2020 2021 2022 2023 2024 2025 £1,632,632 £745,535 (£657,424) (£752,424) (£3,210,476) (£7,912,036) (£5,949,214)
Balance sheet detail
2025202420232022202120202019
Fixed Assets£0£620£961£1,333
Current Assets£0£110,725£28,604£965,140£894,258£1,791,651
Debtors£0£106,708£1,614£340,817£335,231£30,937
Cash£0£4,017£26,990£624,323£559,027£1,760,714
Creditors (< 1 year)£5,949,214£7,912,036£3,321,201£781,028£292,084£149,684£160,352
Creditors (> 1 year)£0£1,331,100
Net Current Assets(£5,949,214)(£7,912,036)(£3,210,476)(£752,424)£673,056£744,574£1,631,299
Net Assets(£752,424)(£657,424)
Shareholder Funds(£5,949,214)(£7,912,036)(£3,210,476)(£752,424)(£657,424)£745,535£1,632,632

Filings

Filing history not loaded yet. See it on Companies House

Some other companies at this address

Other companies in this industry

By trade and location

New companies in Bristol →

Explore the largest companies

Largest companies in Bristol, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?